184 related articles for article (PubMed ID: 37635904)
1. Peripheral metabolic alterations associated with pathological manifestations of Parkinson's disease in gut-brain axis-based mouse model.
Huh E; Choi JG; Lee MY; Kim JH; Choi Y; Ju IG; Eo H; Park MG; Kim DH; Park HJ; Lee CH; Oh MS
Front Mol Neurosci; 2023; 16():1201073. PubMed ID: 37635904
[TBL] [Abstract][Full Text] [Related]
2. 6-Shogaol, an Active Ingredient of Ginger, Improves Intestinal and Brain Abnormalities in
Huh E; Choi JG; Choi Y; Ju IG; Noh D; Shin DY; Kim DH; Park HJ; Oh MS
Biomol Ther (Seoul); 2023 Jul; 31(4):417-424. PubMed ID: 37337830
[TBL] [Abstract][Full Text] [Related]
3. Curcumin-driven reprogramming of the gut microbiota and metabolome ameliorates motor deficits and neuroinflammation in a mouse model of Parkinson's disease.
Cui C; Han Y; Li H; Yu H; Zhang B; Li G
Front Cell Infect Microbiol; 2022; 12():887407. PubMed ID: 36034698
[TBL] [Abstract][Full Text] [Related]
4. Gut Microbiota and Metabolome Alterations Associated with Parkinson's Disease.
Vascellari S; Palmas V; Melis M; Pisanu S; Cusano R; Uva P; Perra D; Madau V; Sarchioto M; Oppo V; Simola N; Morelli M; Santoru ML; Atzori L; Melis M; Cossu G; Manzin A
mSystems; 2020 Sep; 5(5):. PubMed ID: 32934117
[TBL] [Abstract][Full Text] [Related]
5. Role of gut microbiota-derived branched-chain amino acids in the pathogenesis of Parkinson's disease: An animal study.
Yan Z; Yang F; Sun L; Yu J; Sun L; Si Y; Yao L
Brain Behav Immun; 2022 Nov; 106():307-321. PubMed ID: 36126853
[TBL] [Abstract][Full Text] [Related]
6. Metabolic Disturbances in the Gut-brain Axis of a Mouse Model of MPTP-induced Parkinsonism Evaluated by Nuclear Magnetic Resonance.
Pedro Amorim Neto D; Vitor Pereira de Godoy J; Tostes K; Pelegrini Bosque B; Vieira Rodrigues P; Aparecida Rocco S; Luis Sforça M; de Castro Fonseca M
Neuroscience; 2023 Aug; 526():21-34. PubMed ID: 37331688
[TBL] [Abstract][Full Text] [Related]
7. P. mirabilis-derived pore-forming haemolysin, HpmA drives intestinal alpha-synuclein aggregation in a mouse model of neurodegeneration.
Huh E; Choi JG; Choi Y; Ju IG; Kim B; Shin YJ; An JM; Park MG; Yim SV; Chung SJ; Seo SU; Kim D; Kim CH; Kim DH; Oh MS
EBioMedicine; 2023 Dec; 98():104887. PubMed ID: 37995468
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive metabolic profiling of Parkinson's disease by liquid chromatography-mass spectrometry.
Shao Y; Li T; Liu Z; Wang X; Xu X; Li S; Xu G; Le W
Mol Neurodegener; 2021 Jan; 16(1):4. PubMed ID: 33485385
[TBL] [Abstract][Full Text] [Related]
9. Fecal microbiota transplantation protects rotenone-induced Parkinson's disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis.
Zhao Z; Ning J; Bao XQ; Shang M; Ma J; Li G; Zhang D
Microbiome; 2021 Nov; 9(1):226. PubMed ID: 34784980
[TBL] [Abstract][Full Text] [Related]
10. Multi-Omics Integration in Mice With Parkinson's Disease and the Intervention Effect of Cyanidin-3-
Wang W; Zhu G; Wang Y; Li W; Yi S; Wang K; Fan L; Tang J; Chen R
Front Aging Neurosci; 2022; 14():877078. PubMed ID: 35572129
[TBL] [Abstract][Full Text] [Related]
11. Potential roles of gut microbiota and microbial metabolites in Parkinson's disease.
Zheng SY; Li HX; Xu RC; Miao WT; Dai MY; Ding ST; Liu HD
Ageing Res Rev; 2021 Aug; 69():101347. PubMed ID: 33905953
[TBL] [Abstract][Full Text] [Related]
12. Mass spectrometry-based metabolomics: Targeting the crosstalk between gut microbiota and brain in neurodegenerative disorders.
Luan H; Wang X; Cai Z
Mass Spectrom Rev; 2019 Jan; 38(1):22-33. PubMed ID: 29130504
[TBL] [Abstract][Full Text] [Related]
13. Could the Urease of the Gut Bacterium
Grahl MVC; Andrade BDS; Perin APA; Neves GA; Duarte LS; Uberti AF; Hohl KS; Follmer C; Carlini CR
Microorganisms; 2023 Aug; 11(8):. PubMed ID: 37630602
[TBL] [Abstract][Full Text] [Related]
14. Chronic stress-induced gut dysfunction exacerbates Parkinson's disease phenotype and pathology in a rotenone-induced mouse model of Parkinson's disease.
Dodiya HB; Forsyth CB; Voigt RM; Engen PA; Patel J; Shaikh M; Green SJ; Naqib A; Roy A; Kordower JH; Pahan K; Shannon KM; Keshavarzian A
Neurobiol Dis; 2020 Feb; 135():104352. PubMed ID: 30579705
[TBL] [Abstract][Full Text] [Related]
15. Alterations of gut microbiota and metabolome with Parkinson's disease.
Yan Z; Yang F; Cao J; Ding W; Yan S; Shi W; Wen S; Yao L
Microb Pathog; 2021 Nov; 160():105187. PubMed ID: 34530073
[TBL] [Abstract][Full Text] [Related]
16. Parkinson's disease: Are gut microbes involved?
Omotosho AO; Tajudeen YA; Oladipo HJ; Yusuff SI; AbdulKadir M; Muili AO; Egbewande OM; Yusuf RO; Faniran ZO; Afolabi AO; El-Sherbini MS
Brain Behav; 2023 Aug; 13(8):e3130. PubMed ID: 37340511
[TBL] [Abstract][Full Text] [Related]
17. Interactions between gut microbiota and Parkinson's disease: The role of microbiota-derived amino acid metabolism.
Wang W; Jiang S; Xu C; Tang L; Liang Y; Zhao Y; Zhu G
Front Aging Neurosci; 2022; 14():976316. PubMed ID: 36408101
[TBL] [Abstract][Full Text] [Related]
18. Plasma Metabolic Disturbances in Parkinson's Disease Patients.
Gątarek P; Sekulska-Nalewajko J; Bobrowska-Korczaka B; Pawełczyk M; Jastrzębski K; Głąbiński A; Kałużna-Czaplińska J
Biomedicines; 2022 Nov; 10(12):. PubMed ID: 36551761
[TBL] [Abstract][Full Text] [Related]
19. The role of the microbiota-gut-brain axis and intestinal microbiome dysregulation in Parkinson's disease.
Li Q; Meng LB; Chen LJ; Shi X; Tu L; Zhou Q; Yu JL; Liao X; Zeng Y; Yuan QY
Front Neurol; 2023; 14():1185375. PubMed ID: 37305758
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of the
Li D; You HJ; Hu GJ; Yao RY; Xie AM; Li XY
Front Nutr; 2022; 9():945356. PubMed ID: 36687704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
